Announce Date | 04/16/2025 |
EPS Normalized Actual | $1.91 (Beat by $1.125) |
EPS GAAP Actual | $1.91 (Beat by $1.125) |
Revenue Actual | $11.81B |
Revenue Surprise | Beat by $11810M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $3.86173 |
EPS GAAP Estimate | $3.86173 |
Revenue Estimate | $12.156943398B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 26.05232 | 10.14 | 24.97763 | 27.54053 | 2 |
Dec 2025 | 19.40778 | 13.61 | 14.49 | 21.19 | 9 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.73 | 1.73 | 11.81B | 4.93% | 11810M |
FQ4 2024 (Dec 2024) | 9.09 | 9.09 | 12.013B | 9.04% | 12013M |
FQ3 2024 (Sep 2024) | 5.54 | 5.54 | 11.904B | 10.66% | 11904M |
FQ2 2024 (Jun 2024) | 2.34 | 2.34 | 11.178B | 9.66% | 11178M |
FQ1 2024 (Mar 2024) | 4.87 | 4.87 | 11.228B | 13.63% | 11228M |
FQ4 2023 (Dec 2023) | 7.12 | 7.12 | 10.927B | 11.81% | 10927M |
FQ3 2023 (Sep 2023) | 1.77 | 1.77 | 10.635B | 12.52% | 10635M |
FQ2 2023 (Jun 2023) | -0.0609 | -0.0609 | 10.098B | 9.53% | 10098M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
3.86173
Consensus Revenue Estimates
12.156943398B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 8.90355 | -- | 8.81481 | 9.00082 | 5 |
FQ3 2027 (Sep 2027) | 5.1188 | -- | 5.06778 | 5.17472 | 5 |
FQ2 2027 (Jun 2027) | 4.04721 | -- | 4.00687 | 4.09143 | 5 |
FQ1 2027 (Mar 2027) | 7.32707 | -- | 7.25404 | 7.40712 | 5 |
FQ4 2026 (Oct 2026) | 4.82932 | -- | 4.68441 | 4.98912 | 7 |
FQ3 2026 (Jul 2026) | 4.41825 | -- | 4.28567 | 4.56445 | 7 |
FQ2 2026 (Jun 2026) | 4.4858 | -- | 4.32955 | 4.71728 | 7 |
FQ1 2026 (Mar 2026) | 6.39865 | 72.96 | 6.17577 | 6.72884 | 9 |
FQ4 2025 (Oct 2025) | 4.5834 | -98.32 | 4.44587 | 4.73506 | 8 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 12.81B | -- | 12.71B | 12.92B | 7 |
FQ3 2027 (Sep 2027) | 13.57B | -- | 13.47B | 13.69B | 4 |
FQ2 2027 (Jun 2027) | 13.47B | -- | 13.36B | 13.58B | 4 |
FQ1 2027 (Mar 2027) | 12.3B | -- | 12.2B | 12.4B | 7 |
FQ4 2026 (Oct 2026) | 13.39B | -- | 13.08B | 13.73B | 5 |
FQ3 2026 (Jul 2026) | 13.13B | -- | 12.83B | 13.46B | 5 |
FQ2 2026 (Jun 2026) | 13.03B | -- | 12.68B | 13.55B | 5 |
FQ1 2026 (Mar 2026) | 11.91B | 0.8 | 11.59B | 12.38B | 5 |
FQ4 2025 (Oct 2025) | 12.34B | 2.68 | 12.06B | 12.66B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.73 | 1.73 | 100% | |
FQ4 2024 (Dec 2024) | 9.09 | 9.09 | 100% | |
FQ3 2024 (Sep 2024) | 5.54 | 5.54 | 100% | |
FQ2 2024 (Jun 2024) | 2.34 | 2.34 | 100% | |
FQ1 2024 (Mar 2024) | 4.87 | 4.87 | 100% | |
FQ4 2023 (Dec 2023) | 7.12 | 7.12 | 100% | |
FQ3 2023 (Sep 2023) | 1.77 | 1.77 | 100% | |
FQ2 2023 (Jun 2023) | -0.0609 | -0.0609 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $11.81B | $11810M | 100% |
FQ4 2024 (Dec 2024) | $0B | $12.01B | $12013M | 100% |
FQ3 2024 (Sep 2024) | $0B | $11.9B | $11904M | 100% |
FQ2 2024 (Jun 2024) | $0B | $11.18B | $11178M | 100% |
FQ1 2024 (Mar 2024) | $0B | $11.23B | $11228M | 100% |
FQ4 2023 (Dec 2023) | $0B | $10.93B | $10927M | 100% |
FQ3 2023 (Sep 2023) | $0B | $10.64B | $10635M | 100% |
FQ2 2023 (Jun 2023) | $0B | $10.1B | $10098M | 100% |